Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in
Biogen Inc banner

Biogen Inc
LSE:0R1B

Watchlist Manager
Biogen Inc Logo
Biogen Inc
LSE:0R1B
Watchlist
Price: 246.5595 USD -2.45% Market Closed
Market Cap: $36B
Write Note Create Alert

Intrinsic Value

Is 0R1B undervalued or overvalued?

See the intrinsic value estimate for Biogen Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

0R1B Intrinsic Value
LOCKED
Unlock
Today vs. history

0R1B looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with 0R1B’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor 0R1B
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price $246.56
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to 0R1B

Fundamental Analysis

What Biogen Does

Biotechnology Health Care

Biogen is a biotechnology company that develops and sells medicines for serious diseases, with a long focus on conditions that affect the brain and nervous system. Its main products are prescription drugs for diseases such as multiple sclerosis, spinal muscular atrophy, Alzheimer’s disease, and certain rare neurological disorders. It also works on therapies for immunology and related areas, but its business is centered on specialty medicines that are prescribed by doctors rather than sold over the counter.

Headquarters
United States of America US
Employees
7 500
IPO date
Sep 17, 1991
Read the full company overview
View Company Overview

Biogen has a narrow economic moat

No Moat Narrow Wide

Patents and legal protection against competing copies prevent rivals from freely copying several of Biogen’s medicines, helping protect their sales and profits. That protection applies to individual drugs rather than the whole company, while competing treatments already give patients alternatives in important markets.

Read the full moat analysis
Financials
Efficiency

Earnings Waterfall
Biogen Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

BIIB Insider Trading
Buy and sell transactions by insiders

Continue 0R1B Research

Summary
0R1B intrinsic value, competitors valuation, and company profile.
DCF Valuation
0R1B stock valuation using Discount Cash Flow valuation method.
Relative Valuation
0R1B stock valuation using valuation multiples.
Wall St Estimates
0R1B price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
0R1B stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
Other Biogen Inc listings:
NASDAQ • USD
BIIB
 XETRA • EUR
IDP
 F • EUR
IDP
 XHAM • EUR
IDP
 BMV • MXN
BIIB
 XMUN • EUR
IDP
 SWB • EUR
IDP
 DUS • EUR
IDP
 SGO • USD
BIIB
Discover More
What is the Intrinsic Value of one 0R1B stock?

The intrinsic value for Biogen Inc (0R1B) under the Base Case is hidden USD.

Is 0R1B stock undervalued or overvalued?

Compared with the current market price of 246.5595 USD, the stock appears hidden.

Back to Top
ALPHA SPREAD
Follow us
Join 363,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.